Literature DB >> 16943585

Pancreatic islet function in omega3 fatty acid-depleted rats: Glucose metabolism and nutrient-stimulated insulin release.

Berrin Oguzhan1, Ying Zhang, Karim Louchami, Philippe Courtois, Laurence Portois, Jean-Michel Chardigny, Willy J Malaisse, Yvon A Carpentier, Abdullah Sener.   

Abstract

In order to gain information on the determinism of the perturbation of fuel homeostasis in situations characterized by a depletion in long-chain polyunsaturated omega3 fatty acids (omega3), the metabolic and hormonal status of omega3-depleted rats (second generation) was examined. When required, these rats were injected intravenously 120 min before sacrifice with a novel medium-chain triglyceride-fish oil emulsion able to provoke a rapid and sustained increase of the omega3 content in cell phospholipids. The measurement of plasma glucose, insulin, phospholipid, triglyceride, and unesterified fatty acid concentration indicated modest insulin resistance in the omega3-depleted rats. The plasma triglyceride and phospholipid concentrations were decreased in the omega3-depleted rats with abnormally low contribution of omega3 in both circulating and pancreatic islet lipids. The protein, insulin, and lipid content of the islets, as well as their intracellular and extracellular spaces, were little affected in the omega3-depleted rats. The metabolism of D-glucose in the islets of omega3-depleted rats was characterized by a lesser increase in D-[5-3H]glucose utilization and D-[U-14C]glucose oxidation in response to a given rise in hexose concentration and an abnormally low ratio between D-glucose oxidation and utilization. These abnormalities could be linked to an increased metabolism of endogenous fatty acids with resulting alteration of glucokinase kinetics. The release of insulin evoked by D-glucose, at a close-to-physiological concentration (8.3 mM), was increased in the omega3-depleted rats, this being considered as consistent with their insulin resistance. Relative to such a release, that evoked by a further rise in D-glucose concentration or by non-glucidic nutrients was abnormally high in omega3-depleted rats, and restored to a normal level after of the intravenous injection of the omega3-rich medium-chain triglyceride-fish oil emulsion. Because the latter procedure failed to correct the perturbation of D-glucose metabolism in the islets of omega3-depleted rats, it is proposed that the anomalies in the secretory behaviour of islets in terms of their response to an increase in hexose concentration or non-nutrient secretagogues is mainly attributable to alteration in K+ and Ca2+ handling, as indeed recently documented in separate experiments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943585     DOI: 10.1385/ENDO:29:3:457

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  19 in total

1.  Uptake of D-mannoheptulose by normal and tumoral pancreatic islet cells.

Authors:  R Ramirez; J Rasschaert; A Laghmich; K Louchami; A B Nadi; H Jijakli; M M Kadiata; A Sener; W J Malaisse
Journal:  Int J Mol Med       Date:  2001-06       Impact factor: 4.101

2.  Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice.

Authors:  P A Steerenberg; P K Beekhof; E J M Feskens; C J M Lips; J W M Höppener; R B Beems
Journal:  Diabetes Nutr Metab       Date:  2002-08

3.  Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids.

Authors:  L Zimmer; S Delion-Vancassel; G Durand; D Guilloteau; S Bodard; J C Besnard; S Chalon
Journal:  J Lipid Res       Date:  2000-01       Impact factor: 5.922

4.  Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats.

Authors:  A Chicco; M E D'Alessandro; L Karabatas; R Gutman; Y B Lombardo
Journal:  Ann Nutr Metab       Date:  1996       Impact factor: 3.374

5.  Eicosapentaenoic acid (C20:5) augments glucose-induced insulin secretion from beta-TC3 insulinoma cells.

Authors:  R J Konard; J Z Stoller; Z Y Gao; B A Wolf
Journal:  Pancreas       Date:  1996-10       Impact factor: 3.327

6.  The stimulus-secretion coupling of glucose-induced insulin release. XXXV. The links between metabolic and cationic events.

Authors:  W J Malaisse; J C Hutton; S Kawazu; A Herchuelz; I Valverde; A Sener
Journal:  Diabetologia       Date:  1979-05       Impact factor: 10.122

7.  Long- and medium-chain triacylglycerols in neutral lipid-exchange processes with human plasma low-density lipoproteins.

Authors:  M Richelle; Y A Carpentier; R J Deckelbaum
Journal:  Biochemistry       Date:  1994-04-26       Impact factor: 3.162

8.  Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production.

Authors:  Mark J Holness; Gemma K Greenwood; Nicholas D Smith; Mary C Sugden
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

Review 9.  The importance of the ratio of omega-6/omega-3 essential fatty acids.

Authors:  A P Simopoulos
Journal:  Biomed Pharmacother       Date:  2002-10       Impact factor: 6.529

10.  Acute omega-3 fatty acid enrichment selectively reverses high-saturated fat feeding-induced insulin hypersecretion but does not improve peripheral insulin resistance.

Authors:  Mark J Holness; Nicholas D Smith; Gemma K Greenwood; Mary C Sugden
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

View more
  8 in total

1.  Omega-3 fatty acids control productions of superoxide and nitrogen oxide and insulin content in INS-1E cells.

Authors:  M F Graciano; M Leonelli; R Curi; A R Carpinelli
Journal:  J Physiol Biochem       Date:  2016-07-29       Impact factor: 4.158

Review 2.  The role of polyunsaturated fatty acids (n-3 PUFAs) on the pancreatic β-cells and insulin action.

Authors:  Habtamu Wondifraw Baynes; Seifu Mideksa; Sintayehu Ambachew
Journal:  Adipocyte       Date:  2018-03-14       Impact factor: 4.534

3.  Fatty acid pattern of pancreatic islet lipids in Goto-Kakizaki rats.

Authors:  Marie-Hélène Giroix; Karim Louchami; Yvon A Carpentier; Abdullah Sener; Willy J Malaisse
Journal:  Endocrine       Date:  2009-11-24       Impact factor: 3.633

4.  Direct effects of eicosapentaenoic and docosahexaenoic acids on phospholipid and triglyceride fatty acid pattern, glucose metabolism, 86rubidium net uptake and insulin release in BRIN-BD11 cells.

Authors:  Ying Zhang; Raphael Crutzen; Karim Louchami; Yvon A Carpentier; Abdullah Sener; Willy J Malaisse
Journal:  Endocrine       Date:  2009-04-18       Impact factor: 3.633

5.  Carbamylcholine and ouabain effects on Ca2+ handling and insulin release in islets from rats depleted in long-chain polyunsaturated omega 3 fatty acids.

Authors:  Karim Louchami; Ying Zhang; Yvon A Carpentier; Jean-Michel Chardigny; Willy J Malaisse; André Herchuelz; Abdullah Sener
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

6.  Involvement of gut microbial fermentation in the metabolic alterations occurring in n-3 polyunsaturated fatty acids-depleted mice.

Authors:  Barbara D Pachikian; Audrey M Neyrinck; Laurence Portois; Fabienne C De Backer; Florence M Sohet; Myrjam Hacquebard; Yvon A Carpentier; Patrice D Cani; Nathalie M Delzenne
Journal:  Nutr Metab (Lond)       Date:  2011-06-27       Impact factor: 4.169

7.  Altered K+ fluxes and insulin release in pancreatic islets from omega3 fatty acid-depleted rats.

Authors:  Abdullah Sener; Ying Zhang; Karim Louchami; Berrin Oguzhan; Philippe Courtois; Laurence Portois; Jean-Michel Chardigny; Yvon A Carpentier; Willy J Malaisse
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.925

8.  Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition.

Authors:  B D Pachikian; A M Neyrinck; P D Cani; L Portois; L Deldicque; F C De Backer; L B Bindels; F M Sohet; W J Malaisse; M Francaux; Y A Carpentier; N M Delzenne
Journal:  BMC Physiol       Date:  2008-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.